Application of thin layer chromatography and color tests in the analysis of metronidazole
Metronidazole belongs to the group of antiprotozoal medicines and is a potential object of research in various areas of analytical toxicology.
Aim. To study the metronidazole behavior when developing with color reagents generally accepted and to determine Rf values of metronidazole under chromatographing conditions in the solvent systems generally accepted in forensic toxicology.
Results and discussion. It has been shown that such widely used color reagents as UV-light, iodine vapor, Wagner reagent, acidified iodoplatinate solution can be used for detecting metronidazole on chromatographic plates. Metronidazole gives positive detection results with reagents used in the TLC-screening of extracts from the biological material for substances of basic, acid and neutral nature. It has been proposed to develop metronidazole with the neutral ninhydrin solution, p-dimethylaminobenzaldehyde solution and hydrochloric acid vapors, as well as acidified iodoplatinate solution after keeping the plates in formalin vapors. The chromatographic mobility of metronidazole has been studied in 17 solvents systems; the systems are used as standard mobile phases according to recommendations of the International Association of Forensic Toxicologists for TLC-screening of organic compounds of acid, neutral and basic nature, in the general TLC-screening of organic substances in the Ukrainian forensic toxicological laboratories, and some systems investigated with the purpose of choosing the optimal individual solvents systems for the metronidazole study.
Experimental part. The chromatographic plates Sorbfil® PTLC-IIH-UV and Merck® TLC SILICA GEL 60 were used as thin layers.
Conclusions. The behavior of metronidazole when developing on TLC-plates with two types of a substrate (plastic and glass) and with/without luminophor (or UV-indicator) with commonly used colored reagents has been studied. The Rf values of metronidazole under chromatographing conditions in the standard solvent systems used for TLC-screening of organic compounds of acid, neutral and basic nature have been determined.
Full Text:PDF (Українська)
Brook, I.(2016). Spectrum and treatment of anaerobic infections. Journal of Infection and Chemotherapy, 22 (1), 1–13. https://doi.org/10.1016/j.jiac.2015.10.010
Lamp, K. C., Freeman, C. D., Klutman, N. E., & Lacy, M. K. (1999). Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials. Clinical Pharmacokinetics, 36 (5), 353–373. https://doi.org/10.2165/00003088-199936050-00004
Sobel, R., & Sobel, J. D. (2015). Metronidazole for the treatment of vaginal infections. Expert Opinion on Pharmacotherapy, 16 (7), 1109–1115. https://doi.org/10.1517/14656566.2015.1035255
Pasupuleti, V., Escobedo, A. A., Deshpande, A., Thota, P., Roman, Y., & Hernandez, A. V. (2014). Efficacy of 5-Nitroimidazoles for the Treatment of Giardiasis: A Systematic Review of Randomized Controlled Trials. PLoS Neglected Tropical Diseases, 8 (3), 2733. https://doi.org/10.1371/journal.pntd.0002733
Breccia, A., CavalIeri, B., Adams, G. E. (1982). Nitroimidazoles: Chemistry, Pharmacology, and Clinical Application. Plenum Press,New York.
Moreno, S. N. J., & Docampo, R. (1985). Mechanism of Toxicity of Nitro Compounds Used in the Chemotherapy of Trichomoniasis. Environmental Health Perspectives, 64, 199–208. https://doi.org/10.2307/3430010
Noureldin, M., Krause, J., Jin, L., Ng, V., Tran, M. (2010). Drug-Alcohol Interactions: A Review of Three Therapeutic Classes. U.S. Pharmacist, 35 (11), 29–40.
Karamanakos, P. N., Pappas, P., Boumba, V. A., Thomas, C., Malamas, M., Vougiouklakis, T., & Marselos, M. (2007). Pharmaceutical Agents Known to Produce Disulfiram-Like Reaction: Effects on Hepatic Ethanol Metabolism and Brain Monoamines. International Journal of Toxicology, 26 (5), 423–432. https://doi.org/10.1080/10915810701583010
Cina, S. J., Russell, R. A., & Conradi, S. E. (1996). Sudden Death Due to Metronidazole/Ethanol Interaction. The American Journal of Forensic Medicine and Pathology, 17 (4), 343–346. https://doi.org/10.1097/00000433-199612000-00013
Commission Regulation (EU) №37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. (2010). Official Journal of the European Union, 15, 1–72.
Rose, M. D., Bygrave, J., & Sharman, M. (1999). Effect of cooking on veterinary drug residues in food Part 9.† Nitroimidazoles. The Analyst, 124 (3), 289–294. https://doi.org/10.1039/a809062i
Moffat, A. C., Osselton, M. D., Widdop, B. (2011). Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material. Pharmaceutical Press,London, 4th ed.
Jickells, S., Negrusz, A. (2008). Clarke’s Analytical Forensic Toxicology. Pharmaceutical Press,London,Chicago.
Shkarlat, G. L., Klimenko, L. Yu., Shovkova, Z. V., Havrysh, N. B., Lebedynets, V. O. (2018). Modelling the processes of sample preparation of biological objects for the subsequent determination of metronidazole. Journal of Pharmaceutical Sciences and Research, 10 (3), 474–480.
GOST Style Citations
1. Brook, I. Spectrum and treatment of anaerobic infections / I. Brook // J. Infect. Chemother. – 2016. – Vol. 22, Issue 1. – P. 1–13. https://doi.org/10.1016/j.jiac.2015.10.010
2. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials / K. C. Lamp, C. D. Freeman, N. E. Klutman [et al.] // Clin. Pharmacokinet. – 1999. – Vol. 36, Issue 5. – P. 353–373. https://doi.org/10.2165/00003088-199936050-00004
3. Sobel, R. Metronidazole for the treatment of vaginal infections / R. Sobel, J. D. Sobel // Expert. Opin. Pharmacother. – 2015. – Vol. 16, Issue 7. – P. 1109–1115. https://doi.org/10.1517/14656566.2015.1035255
4. Efficacy of 5-nitroimidazoles for the treatment of giardiasis: a systematic review of randomized controlled trials / V. Pasupuleti, A. A. Escobedo, A. Deshpande [et al.] // PLOS Negl. Trop. Dis. – 2014. – Vol. 8, Issue 3. – 2733. https://doi.org/10.1371/journal.pntd.0002733
5. Breccia, A. Nitroimidazoles: Chemistry, Pharmacology, and Clinical Application / A. Breccia, B. CavalIeri, G. E. Adams. – New York: Plenum Press, 1982. – 214 p.
6. Moreno, S. N. Mechanism of toxicity of nitrocompounds used in the chemotherapy of trichomoniasis / S. N. Moreno, R. Docampo // Environ. Health Perspect. – 1985. – Vol. 64. – P. 199–208. https://doi.org/10.2307/3430010
7. Drug-Alcohol Interactions: A Review of Three Therapeutic Classes / M. Noureldin, J. Krause, L. Jin [et al.] // US Pharm. – 2010. – Vol. 36, Issue 11. – P. 29–40.
8. Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines / P. N. Karamanakos, P. Pappas, V. A. Boumba et al. // Int. J. Toxicol. – 2007. – Vol. 26, Issue 5. – P. 423–432. https://doi.org/10.1080/10915810701583010
9. Cina, S. J. Sudden death due to metronidazole – ethanol interaction / S. J. Cina, R. A. Russell, S. E. Conradi // Am. J. Forensic Med. Pathol. – 1996. – Vol. 17. – P. 343–346. https://doi.org/10.1097/00000433-199612000-00013
10. Commission Regulation (EU) № 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin // Official J. of the Eur. Union. – 2010. – L. 15. – P. 1–72.
11. Rose, M. D. Effect of cooking on veterinary drug residues in food. Part 9. Nitroimidazoles / M. D. Rose, J. Bygrave, M. Sharman // Analyst. – 1999. – Vol. 124, Issue 3. – P. 289–294. https://doi.org/10.1039/a809062i
12. Clarke’s analysis of drugs and poisons in pharmaceuticals, body fluids and postmortem material / ed. by A. C. Moffat, M. D. Osselton, B. Widdop: 4th ed. – London : Pharmaceutical Press, 2011. – 2609 p.
13. Clarke’s Analytical Forensic Toxicology / ed. by S. Jickells, A. Negrusz. –London:Chicago: Pharmaceutical Press, 2008. – 648 p.
14. Modelling the processes of sample preparation of biological objects for the subsequent determination of metronidazole / G. L. Shkarlat, L. Yu. Klimenko, Z. V. Shovkova [et al.] // J. Pharm. Sci. Res. – 2018. – Vol. 10, Issue 3. – P. 474–480.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abbreviated key title: J. Org. Pharm. Chem.
ISSN 2518-1548 (Online), ISSN 2308-8303 (Print)